By Mill Chart
Last update: Mar 18, 2024
Consider THE CIGNA GROUP (NYSE:CI) as a top value stock, identified by our stock screening tool. NYSE:CI shines in terms of profitability, solvency, and liquidity, all while remaining very reasonably priced. Let's dive deeper into the analysis.
ChartMill assigns a proprietary Valuation Rating to each stock. The score is computed by evaluating various valuation aspects, like price to earnings and free cash flow, both absolutely as relative to the market and industry. NYSE:CI was assigned a score of 7 for valuation:
ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NYSE:CI has earned a 6 out of 10:
ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NYSE:CI, the assigned 5 reflects its health status:
ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NYSE:CI has earned a 7 for growth:
Every day, new Decent Value stocks can be found on ChartMill in our Decent Value screener.
Check the latest full fundamental report of CI for a complete fundamental analysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
THE CIGNA GROUP
NYSE:CI (4/19/2024, 11:40:38 AM)
351.695
+2.92 (+0.84%)
Cigna (CI) closed at $348.78 in the latest trading session, marking a +0.78% move from the prior day.
/PRNewswire/ -- As part of its ongoing commitment to community health and vitality, global health company The Cigna Group (NYSE: CI) today announced a...
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
/PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2024 financial results on Thursday, May 2, 2024, and will host a...
/PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) has been recognized for excellence in employee health and well-being by the Business Group on...
THE CIGNA GROUP (NYSE:CI) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Looking for growth without the hefty price tag? Consider THE CIGNA GROUP (NYSE:CI).
The indexes and leading stocks are generally holding key levels.